PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63278-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)63278-0/fulltext
Title :
PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63278-0&doi=10.1016/S1098-3015(10)63278-0
First page :
Section Title :
Open access? :
No
Section Order :
129